We are live on !
Find out more
De Burlo Group Portfolio holdings
AUM
$569M
Turnover
18%
1-Year Est. Return
41.68%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+41.68%
3 Year Est. Return
+164.02%
5 Year Est. Return
+296.64%
10 Year Est. Return
+2,418.32%
AUM
$411M
AUM Growth
+$50.3M
(+14%)
Cap. Flow
+$49.2M
Cap. Flow % of AUM
Cap. Flow %
11.98%
Top 10 Holdings %
Top 10 Hldgs %
32.14%
Holding
110
New
12
Increased
20
Reduced
51
Closed
15
Avg Time Held
1.8
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognex
CGNX
|
+$13.5M |
| 2 |
Citigroup
C
|
+$12.5M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$10.2M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$10M |
| 5 |
Bank of New York Mellon
BNY
|
+$9.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$6.46M |
| 2 |
Edwards Lifesciences
EW
|
+$5.78M |
| 3 |
Crown Castle
CCI
|
+$5.48M |
| 4 |
AvalonBay Communities
AVB
|
+$5.09M |
| 5 |
Zimmer Biomet
ZBH
|
+$3.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.85% |
| 2 | Healthcare | 19.87% |
| 3 | Financials | 18.27% |
| 4 | Communication Services | 9.26% |
| 5 | Consumer Discretionary | 8.01% |
Similar funds
RMI
De Burlo Group's Q4 2016 Portfolio in Review
As of Q4 2016, De Burlo Group held 110 positions worth $411M, up 14% from $360M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
De Burlo Group deployed $49.2M of net new capital in Q4 2016, opening 12 new positions and adding to 20 existing holdings. Its largest new stake was Cognex: 470,800 shares worth $15M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $6.46M trimmed.
- De Burlo Group's largest Q4 2016 buy was Cognex: 470,800 shares worth $15M.
- De Burlo Group added most to Berkshire Hathaway Class B in Q4 2016, an estimated $10M increase.
- De Burlo Group's biggest Q4 2016 reduction was Thermo Fisher Scientific, cutting an estimated $6.46M.
- De Burlo Group fully exited AvalonBay Communities in Q4 2016, selling an estimated $5.09M.
- De Burlo Group's ten largest holdings make up 32% of its $411M portfolio in Q4 2016.
- De Burlo Group opened 12 new positions and closed 15 in Q4 2016.
- De Burlo Group's portfolio value rose 14% quarter-over-quarter to $411M.
Based on De Burlo Group's 13F filing for Q4 2016, filed 10 Feb 2017.